Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezekowitz

Showing results (561-570 of 842) with videos related to

Pageof 85
Sort By:
American Heart Journal|June 2, 2015
The future of cardiovascular clinical research in North America and beyond-addressing challenges and leveraging opportunities through unique academic and grassroots collaborationsMatthew T Roe, Kenneth W Mahaffey, Justin A Ezekowitz, et al.
Journal of the American College of Cardiology|July 2, 2011
Percutaneous tricuspid valve replacement in congenital and acquired heart diseasePhilip A Roberts, Younes Boudjemline, John P Cheatham, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 6, 2016
Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillationMichael D Ezekowitz, John Eikelboom, Jonas Oldgren, et al.
Circulation. Heart Failure|August 19, 2021
Participation in a Heart Failure Clinical Trial: Perspectives and Opportunities From the VICTORIA Trial and VICTORIA Simultaneous RegistryJustin Ezekowitz, Robert J Mentz, Cynthia M Westerhout, et al.
Journal of Medicinal Chemistry|August 2, 2018
Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological DisordersJustin S Cisar, Olivia D Weber, Jason R Clapper, et al.
Circulation. Arrhythmia and Electrophysiology|May 2, 2022
Drug Interactions Affecting Antiarrhythmic Drug UsePhilip L Mar, Piotr Horbal, Mina K Chung, et al.
Journal of the American College of Cardiology|September 2, 2025
Pharmacological Treatment of Heart Failure with Reduced Ejection Fraction: An Updated Systematic Review and Network Meta-AnalysisBart J van Essen, Daan C H Ceelen, Wouter Ouwerkerk, et al.
International Immunopharmacology|May 19, 2001
Recombinant expression of human mannan-binding lectinT Vorup-Jensen, E S Sørensen, U B Jensen, et al.
JACC. Heart Failure|January 23, 2026
Standardized Reporting in Heart Failure Noninvasive Remote Monitoring Trials: Interventions to Catalyze Data Into ActionElise L Shalowitz, Pardeep Jhund, Mitchell A Psotka, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 25, 2017
Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trialVidal Essebag, Riccardo Proietti, David H Birnie, et al.
Pageof 85

Showing results (561-570 of 842) with videos related to

Sort By:
Pageof 85
American Heart Journal|June 2, 2015
The future of cardiovascular clinical research in North America and beyond-addressing challenges and leveraging opportunities through unique academic and grassroots collaborationsMatthew T Roe, Kenneth W Mahaffey, Justin A Ezekowitz, et al.
Journal of the American College of Cardiology|July 2, 2011
Percutaneous tricuspid valve replacement in congenital and acquired heart diseasePhilip A Roberts, Younes Boudjemline, John P Cheatham, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 6, 2016
Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillationMichael D Ezekowitz, John Eikelboom, Jonas Oldgren, et al.
Circulation. Heart Failure|August 19, 2021
Participation in a Heart Failure Clinical Trial: Perspectives and Opportunities From the VICTORIA Trial and VICTORIA Simultaneous RegistryJustin Ezekowitz, Robert J Mentz, Cynthia M Westerhout, et al.
Journal of Medicinal Chemistry|August 2, 2018
Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological DisordersJustin S Cisar, Olivia D Weber, Jason R Clapper, et al.
Circulation. Arrhythmia and Electrophysiology|May 2, 2022
Drug Interactions Affecting Antiarrhythmic Drug UsePhilip L Mar, Piotr Horbal, Mina K Chung, et al.
Journal of the American College of Cardiology|September 2, 2025
Pharmacological Treatment of Heart Failure with Reduced Ejection Fraction: An Updated Systematic Review and Network Meta-AnalysisBart J van Essen, Daan C H Ceelen, Wouter Ouwerkerk, et al.
International Immunopharmacology|May 19, 2001
Recombinant expression of human mannan-binding lectinT Vorup-Jensen, E S Sørensen, U B Jensen, et al.
JACC. Heart Failure|January 23, 2026
Standardized Reporting in Heart Failure Noninvasive Remote Monitoring Trials: Interventions to Catalyze Data Into ActionElise L Shalowitz, Pardeep Jhund, Mitchell A Psotka, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 25, 2017
Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trialVidal Essebag, Riccardo Proietti, David H Birnie, et al.
Pageof 85